Since the 1960’s the Centers for Disease Control and Prevention has been investing heavily in the understand and prevention of central line-associated bloodstream infections.  That investment has paid dividends, based on the findings in a study from Health Affairs (http://content.healthaffairs.org/content/33/6/1040.abstract).